Injectable Block Copolymer Hydrogels: Achievements and Future Challenges for Biomedical Applications
- 4 August 2011
- journal article
- review article
- Published by American Chemical Society (ACS) in Macromolecules
- Vol. 44 (17) , 6629-6636
Abstract
No abstract availableKeywords
This publication has 128 references indexed in Scilit:
- In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymerBiomaterials, 2011
- Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardiumBiomaterials, 2011
- Delivery of rosiglitazone from an injectable triple interpenetrating network hydrogel composed of naturally derived materialsBiomaterials, 2011
- In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growthInternational Journal of Pharmaceutics, 2010
- Injectable pH- and Temperature-Responsive Poly(N-isopropylacrylamide-co-propylacrylic acid) Copolymers for Delivery of Angiogenic Growth FactorsBiomacromolecules, 2010
- Hydrogel biomaterials: A smart future?Biomaterials, 2007
- Novel pH and temperature-sensitive block copolymers: Poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(β-amino ester)Macromolecular Research, 2006
- Synthesis and thermal responsive properties of P(LA-b-EO-b-PO-b-EO-b-LA) block copolymers with short hydrophobic poly(lactic acid) (PLA) segmentsPolymer, 2005
- Thermosensitive sol–gel reversible hydrogelsAdvanced Drug Delivery Reviews, 2002
- Hydrogels for biomedical applicationsAdvanced Drug Delivery Reviews, 2002